California Institute for Regenerative Medicine
South San Francisco, Californiaca.gov
Overview
California Institute for Regenerative Medicine is a state agency that funds research and clinical trials in stem cell, gene therapy, and regenerative medicine to accelerate the development of transformative treatments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Siren Biotechnology | Jun 2026 | Grant | Co-investor |
| Tr1X | Jun 2026 | Grant | Co-investor |
| Scribe Therapeutics | Jun 2026 | Grant | Co-investor |
| AcuraStem | Apr 2026 | Grant | Co-investor |
| Immusoft | Mar 2026 | Grant | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
